Table 2.

Minimum Inhibitory Concentration based Antibiotic Susceptibility Pattern of Ocular Clinical Isolates of P. aeruginosa (n = 34).

Antibiotic	MIC (μg/mL)	% Isolates
		Susceptible (S)	Intermediate (I)	Resistant (R)
Chloramphenicol (CHL)	0.016–256	6	6	88
Ciprofloxacin (CIP)	0.25–4	70	12	18
Moxifloxacin (MXF)	0.002–32	12	6	82
Gatifloxacin (GAT)	0.002–32	79	0	21
Ofloxacin (OFX)	0.002–32	79	0	21
Levofloxacin (LEV)	0.12–8	62	0	38
Gentamycin (GEM)	1–16	82	0	18
Amikacin (AKN)	2–64	85	0	15
Tobramycin (TOB)	0.016–256	82	0	18
Colistin (CS)	0.5–16	100	0	0
Ceftazidime (CAZ)	1–64	62	0	38
Cefepime (CEP)	1–64	67	18	15
Imipenem (IPM)	0.25–16	85	0	15
Doripenem (DOR)	0.12–8	79	9	12
Meropenem (MEM)	0.25–16	85	3	12
Piperacillin/Tazobactam (TZP)	4/4/–128/4	35	15	50
Ticarcillin/Clavulanic Acid (TIM)	8/2–128/2	9	44	47
Cefoperazone/Sublactam (CPZ)	8–64	32	44	24
Tigercycline (TGC)	0.5–8	0	0	100